University of Michigan Rogel Cancer Center: Pancreatic Neoplasms trials

The registry lists 12 Pancreatic Neoplasms studies with University of Michigan Rogel Cancer Center as lead sponsor. 0 are open to participants now and 6 have results posted.

Phase 1 4Phase 2 5No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Michigan Genetic Hereditary Testing (MiGHT)CompletedNCT05162846Not applicableResults posted
• A Trial of Cabozantinib (XL184) and Gemcitabine in Advanced Pancreatic CancerCompletedNCT01663272Phase 1Results posted
• A Study of Neoadjuvant FOLFIRINOX and FDR-Gemcitabine With Concurrent IMRT in PatientsCompletedNCT01661088Phase 2Results posted
• A Pilot Study Assessing Intra-Metastasis Administration of Autologous KLH-pulsed Dendritic Cells With Tumoral Radiation Therapy in Patients With Metastatic Pancreatic CarcinomaTerminatedNCT00843830Phase 1Results posted
• Dose-Escalation Study of Intensity-Modulated Radiotherapy(IMRT)in Patients With Unresectable Pancreatic CancerCompletedNCT00593866Phase 1/2Results posted
• Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic CancerCompletedNCT00456599Phase 2Results posted
• A Pilot Trial to Determine the Extent of Inter- and Intra-Treatment Organ Motion Using Active Breathing Control Device (ABC) in Patients With Pancreatic CancerCompletedNCT01986738
• A Pilot Study of Diffusion MRI in the Assessment of Pancreatic Tumor ResponseCompletedNCT01209962
• UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With CancerCompletedNCT00900094
• Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic CancerCompletedNCT00242190Phase 1/2
• Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic CancerCompletedNCT00176813Phase 2
• Capecitabine and Radiation Therapy in Advanced Pancreatic CancerTerminatedNCT00176735Not applicable